Pendapatan dodolan perusahaan Pieris Pharmaceuticals, Inc. (PIRS)

Lambang korporat lan logo Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals (PIRS) is developing the Anticalin platform for the treatment of cancer and respiratory pathologies, leveraging clinical trial data and cost optimization. This chart illustrates the company's sales figures as reported by the GURU.Markets system, where 0.00 represents the latest metric reading. External contractors support development efficiency to maintain expenditure flexibility. Capitalization is based on royalties and upfront payments from global pharma behemoths for innovative protein-based drugs.

PIRS (Pieris Pharmaceuticals) riwayat Pendapatan lan volume dodolan saka 04.07.2022 nganti 15.11.2026

Rincian analitis perusahaan Pieris Pharmaceuticals

- rega pasar lan target rega analis:
Ringkesan analisis perusahaan:Pieris Pharmaceuticals
Produk asli Pieris Pharmaceuticals Inc

Pieris Pharmaceuticals (PIRS) gross sales volume reflects the monetization efficiency of the Anticalin platform through licensing fees and royalties, determining the inertial value of the assets. This indicator measures total incoming cash flow, excluding reporting time lags, allowing investors to assess the business's fundamental ability to generate revenue and balance potential returns against the risks of a market drawdown.

Analisis perusahaan pesaing

HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Pendapatan perusahaan|AMRX - Pendapatan perusahaan|Total pendapatan perusahaan perrigo.com|ALVO (Alvotech SA) - Dodolan perusahaan|Total volume dodolan perusahaan Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Pendapatan lan volume dodolan|ANIP: Pendapatan dodolan perusahaan|Pendapatan perusahaan Afrezza (MNKD)|Pendapatan lan volume dodolan amphastar.com (AMPH)|Pendapatan lan volume dodolan PCRX (pacira.com)|Pendapatan dodolan perusahaan SPRY|Theravance Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Aquestive Therapeutics AQST|SCPH: Pendapatan lan volume dodolan|Dodolan perusahaan Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Pendapatan lan volume dodolan|SXTC (China SXT Pharmaceuticals, Inc.) - Total dodolan perusahaan|Pendapatan perusahaan eupraxiapharma.com (EPRX)|Total dodolan perusahaan BHST|Pendapatan perusahaan eXoZymes EXOZ|Pendapatan dodolan perusahaan ORMP|ENTX - Pendapatan perusahaan|HYFT: Pendapatan perusahaan|ABVC BioPharma, Inc (ABVC) - Pendapatan perusahaan|Cumberland Pharma - Pendapatan dodolan perusahaan|QNTM (Quantum BioPharma Corp) - Pendapatan lan volume dodolan|FibroGen, Inc. - Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan TELO|Pendapatan reged perusahaan Rani Therapeutics Holdings, Inc.|Pendapatan perusahaan Synergy CHC Corp. SNYR|Pendapatan lan volume dodolan rallybio.com RLYB|Lexaria Bioscience Corp. - Pendapatan lan volume dodolan|PULM: Pendapatan perusahaan|PTHL (ftzy.com.cn) - Dodolan perusahaan|APM: Total dodolan perusahaan|LYRA (Lyra Therapeutics Inc) - Pendapatan lan volume dodolan|Volume dodolan perusahaan IBO (Impact BioMedical)|Dodolan perusahaan TNFA (TNF Pharmaceuticals)|Pendapatan lan volume dodolan cbdMD Corp (YCBD)|Pendapatan lan volume dodolan PRFX (PainReform)|Pendapatan reged perusahaan Auris Medical (CYTO)|LIPO - Pendapatan perusahaan|Optinose (OPTN) - Dodolan perusahaan|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP